SCHEMBL19218463

SCHEMBL19218463

c1cc(-c2ccc(N(c3ccc4c(c3)C3(c5ccccc5-c5ccccc53)c3ccccc3-4)c3ccc4c5ccccc5c5ccccc5c4c3)cc2)cc(-c2ccc3oc4ccccc4c3c2)c1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.34
PLA2G4A P47712 3/20 0.34
PLA2G10 O15496 1/20 0.34
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
AHR P35869 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ALOX5 P09917 1/20 0.31
PDK2 Q15119 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19218457 0.97 HSP90AA1 (0.34) PLA2G2APLA2G4AHSP90AA1HSP90AB1AHR
SCHEMBL19218446 0.97 HSP90AA1 (0.34) PLA2G2APLA2G4AHSP90AA1HSP90AB1AHR
SCHEMBL19218734 0.96 HSP90AA1 (0.34) PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1
SCHEMBL19218450 0.95 PLA2G2A (0.33) PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1
SCHEMBL19218462 0.95 PLA2G2A (0.34) PLA2G2APLA2G4APLA2G10AHRKDM4E
SCHEMBL19218683 0.95 HSP90AA1 (0.34) PLA2G2APLA2G4AHSP90AA1HSP90AB1AHR
SCHEMBL19218535 0.94 PLA2G2A (0.34) PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1
SCHEMBL17806871 0.93 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1
SCHEMBL16996328 0.92 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1
SCHEMBL16996331 0.92 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10243148-B2 Aromatic amine compound, and organic electroluminescent elements including the compound IDEMITSU KOSAN CO., LTD. (JP) 2019-03-26 US disclosed
US-20170229649-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-08-10 US disclosed
US-20170229649-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10243148-B2 Aromatic amine compound, and organic electroluminescent elements including the compound H1-10, H1-0, H1-4 PLA2G2A 3413/4885PLA2G4A 3637/4885PLA2G10 2984/4885
US-20170229649-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, LEF1, PIEZO1 PLA2G2A 2128/4885PLA2G4A 2479/4885PLA2G10 1564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.